Dr. Lauren B. Krupp, MD

Dr. Krupp practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Krupp's NPI, 1447207154, was assigned on May 28, 2006. Dr. Krupp graduated from Albert Einstein College of Medicine of Yeshiva University in 1981. Dr. Krupp holds New York license 159491.

Dr. Krupp's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Krupp's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Krupp is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Krupp to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Krupp practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Krupp's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Krupp is licensed in New York.

CMS data shows 105 Medicare services from Dr. Krupp across 3 procedure codes in 2024, for 49 Medicare patients. Medicare paid $10,243 for them. Every service was in an office.

CMS counts 49 Medicare patients who saw Dr. Krupp in 2024. The largest group is 65 to 74, with 30 patients. 67% of them have high cholesterol, and 47% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Krupp's median patient age at 39, with 69% women.

In 2024, Dr. Krupp wrote 334 Medicare Part D claims for 46 patients. 85% of them were for generic drugs. CMS names the drug for 220 of them, across 8 drugs with 11 or more claims each, at $342,030 in total drug cost. In 2023, CMS named 199 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Krupp for performance year 2024, reported as part of a group. Dr. Krupp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Krupp as offering telehealth.

Dmand AI links 159 papers to Dr. Krupp, published from 2010 to 2025. 2021 was the busiest year, with 14. The most frequent topics are Multiple Sclerosis, Neuropsychological Tests and Cognition Disorders. Dr. Krupp has published most often in Mult Scler. Dr. Krupp's most frequent co-authors are Tanuja Chitnis, MD, Anita Belman and Jayne M. Ness, MD.

Dmand AI links Dr. Krupp to 3 clinical trials. Conditions studied include Multiple Sclerosis, Hepatitis C and Multiple Sclerosis, Relapsing-Remitting. Open Payments lists research payments to Dr. Krupp that name 1 trial.

CMS Open Payments shows 106 general payments to Dr. Krupp from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 44% of the total. Sanofi and Genzyme US Companies paid the most, $44,818. It also lists 45 research payments totaling $52,115 from 2016 to 2025, naming 1 clinical trial.

Dr. Krupp graduated from Albert Einstein College of Medicine of Yeshiva University in 1981.